Logo image of BTRS

BTRS HOLDINGS INC-CL 1 (BTRS) Stock Fundamental Analysis

NASDAQ:BTRS - Nasdaq - US11778X1046 - Common Stock - Currency: USD

9.49  -0.01 (-0.11%)

After market: 9.49 0 (0%)

Fundamental Rating

2

BTRS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. While BTRS seems to be doing ok healthwise, there are quite some concerns on its profitability. BTRS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BTRS had negative earnings in the past year.
In the past year BTRS has reported a negative cash flow from operations.
BTRS Yearly Net Income VS EBIT VS OCF VS FCFBTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -20M -40M -60M

1.2 Ratios

The profitability ratios for BTRS are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BTRS Yearly ROA, ROE, ROICBTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -5 -10 -15

1.3 Margins

BTRS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BTRS Yearly Profit, Operating, Gross MarginsBTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

BTRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
BTRS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BTRS has a worse debt to assets ratio.
BTRS Yearly Shares OutstandingBTRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 50M 100M 150M
BTRS Yearly Total Debt VS Total AssetsBTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

BTRS has an Altman-Z score of 5.05. This indicates that BTRS is financially healthy and has little risk of bankruptcy at the moment.
BTRS's Altman-Z score of 5.05 is fine compared to the rest of the industry. BTRS outperforms 77.67% of its industry peers.
BTRS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
BTRS's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. BTRS outperforms 62.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACCN/A
WACC10.26%
BTRS Yearly LT Debt VS Equity VS FCFBTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

BTRS has a Current Ratio of 2.15. This indicates that BTRS is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.15, BTRS perfoms like the industry average, outperforming 57.67% of the companies in the same industry.
A Quick Ratio of 2.15 indicates that BTRS has no problem at all paying its short term obligations.
With a Quick ratio value of 2.15, BTRS perfoms like the industry average, outperforming 58.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
BTRS Yearly Current Assets VS Current LiabilitesBTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

BTRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.58%.
Looking at the last year, BTRS shows a very strong growth in Revenue. The Revenue has grown by 53.12%.
EPS 1Y (TTM)-31.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
Revenue 1Y (TTM)53.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.19%

3.2 Future

BTRS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.45% yearly.
BTRS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.43% yearly.
EPS Next Y-18.52%
EPS Next 2Y17.4%
EPS Next 3Y14.59%
EPS Next 5Y2.45%
Revenue Next Year29.05%
Revenue Next 2Y25.59%
Revenue Next 3Y23.81%
Revenue Next 5Y18.43%

3.3 Evolution

BTRS Yearly Revenue VS EstimatesBTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BTRS Yearly EPS VS EstimatesBTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BTRS. In the last year negative earnings were reported.
Also next year BTRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTRS Price Earnings VS Forward Price EarningsBTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTRS Per share dataBTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

BTRS's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.4%
EPS Next 3Y14.59%

More info and screens

0

5. Dividend

5.1 Amount

BTRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BTRS HOLDINGS INC-CL 1

NASDAQ:BTRS (12/15/2022, 8:00:02 PM)

After market: 9.49 0 (0%)

9.49

-0.01 (-0.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2022-11-07/bmo
Earnings (Next)02-27 2023-02-27
Inst Owners0%
Inst Owner Change0%
Ins Owners0.23%
Ins Owner Change0%
Market Cap1.56B
Analysts75
Price Target10.2 (7.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.28%
Min EPS beat(2)-67.7%
Max EPS beat(2)-30.85%
EPS beat(4)0
Avg EPS beat(4)-72.74%
Min EPS beat(4)-163.39%
Max EPS beat(4)-29%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)16.54%
Min Revenue beat(2)15.28%
Max Revenue beat(2)17.8%
Revenue beat(4)4
Avg Revenue beat(4)19.88%
Min Revenue beat(4)15.28%
Max Revenue beat(4)27.07%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)7.4%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.24%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.26
P/FCF N/A
P/OCF N/A
P/B 6.21
P/tB 16.68
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS1.15
BVpS1.53
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 5.05
F-Score2
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
EPS Next Y-18.52%
EPS Next 2Y17.4%
EPS Next 3Y14.59%
EPS Next 5Y2.45%
Revenue 1Y (TTM)53.12%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.19%
Revenue Next Year29.05%
Revenue Next 2Y25.59%
Revenue Next 3Y23.81%
Revenue Next 5Y18.43%
EBIT growth 1Y-68.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.16%
EBIT Next 3Y29.57%
EBIT Next 5Y15.55%
FCF growth 1Y-3547.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3371.36%
OCF growth 3YN/A
OCF growth 5YN/A